Federal grants to Human Cell Co
Human Cell Co in Naperville, Illinois received $3.5 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Vision Research, with $2.7 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.5 million
- Awards5
- Awarded in FY 2025$0
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $359,500 |
| FY 2022 | 0 | $0 |
| FY 2023 | 2 | $1.4 million |
| FY 2024 | 3 | $1.7 million |
| FY 2025 | 0 | $0 |
Programs that fund Human Cell Co
| Program | Awards | Amount |
|---|---|---|
| Vision Research | 3 | $2.7 million |
| Cancer Biology Research | 1 | $400,000 |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $359,500 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $3.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Optimizing ngf for topical treatment of glaucoma - abstract glaucoma is a leading cause of irreversible vision loss, which is characterized by progressive degeneration of retinal ganglion cells (RGC) and their optic nerve axons. While age is a key risk factor, elevated intraocular pressure (IOP) is | Vision Research | August 24, 2023 | $2.0 million |
| Optimization of til cell manufacturing for cancer treatment - abstract adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) has demonstrated tremendous potential for treatment of advanced solid tumors. Objective response rates ranging from 34 to 72% have been reported in | Cancer Biology Research | February 17, 2023 | $400,000 |
| Topical treatment of an optimized ngf for dry eye - project summary dry eye disease (DED) is an increasingly frequency cause of visual dysfunction. It is characterized by loss of homoeostasis of the ocular surface, resulting in tear film instability, hyperosmolarity, and inflammation of the conjunct | Vision Research | September 12, 2024 | $365,000 |
| Topical ngf therapy and oral nicotinamide supplementation for glaucoma - abstract glaucoma is a leading cause of irreversible vision loss, which is characterized by progressive degeneration of retinal ganglion cells (RGC) and their optic nerve axons. While age is a key risk factor, elevated intraocu | Vision Research | September 6, 2024 | $360,897 |
| Tpa and ngf therapy for stroke - principal investigator/program director (last, first, middle: soon seog jeong abstract due to its narrow time-window of administration (up to 4.5 hours post symptoms) and 6-7 fold increased risk of intracranial hemorrhage, merely 3-5% of acute ischemic stroke patient | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 17, 2021 | $359,500 |
Questions people ask
How much federal grant money does Human Cell Co get?
$3.5 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Human Cell Co the most?
The Department of Health and Human Services, with $3.5 million in 5 awards.
What is Human Cell Co's largest federal grant?
$2.0 million under Vision Research, with its first action in the period on August 24, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Human Cell Co?
Its largest are Vision Research, Cancer Biology Research and Extramural Research Programs in the Neurosciences and Neurological Disorders.
Other grant recipients in Naperville
- North Central College
- 360 Youth Services
- Apt Therapeutics, Inc.
- City of Naperville
- MCHC-Chicago Hospital Council
- Naperville Heritage Society
- Nhanced Semiconductors, Inc.
Largest federal grant recipients in Illinois · Federal grants in Illinois